Germany Myomectomy Market Size, Share, and COVID-19 Impact Analysis, By Type (Abdominal, Hysteroscopic, and Laparoscopic), By Product (Laparoscopic Power Morcellators, Harmonic Scalpel, Laparoscopic Sealer, and Others), and Germany Myomectomy Market Insights, Industry Trend, Forecasts to 2035

Germany Myomectomy Market Forecasts to 2035

• The Germany Myomectomy Market Size Was Estimated at USD 39.8 Million in 2024
• The Germany Myomectomy Market Size is Expected to Grow at a CAGR of around 9.58% from 2025 to 2035
• The Germany Myomectomy Market Size is Expected to Reach USD 108.9 Million by 2035

According to a research report published by Spherical Insights & Consulting, the Germany Myomectomy Market Size is Anticipated to Reach USD 108.9 Million by 2035, Growing at a CAGR of 9.58% from 2025 to 2035. The market for myomectomy is growing because of the rise in uterine fibroids, the need for minimally invasive, fertility-preserving operations such laparoscopic and robotically assisted surgeries, and advancements in incisionless, high-energy wave technologies that improve recovery and safety.

Market Overview

The German myomectomy market, which refers to the surgical removal of uterine fibroids while preserving the uterus, is classified as a non-economic sector. This market includes treatments for uterine fibroids, which are non-cancerous growths in the uterus that can cause a variety of symptoms and consequences, as well as the technologies, surgeries, and services related to them. The rising prevalence of uterine fibroids, as well as the growing demand for less invasive treatment approaches, are significant reasons driving myomectomy growth. The growing incidence of uterine fibroids and the growing need for less invasive and uterus-preserving procedures are driving the robust expansion of the myomectomy market in Germany. A myomectomy eliminates fibroids while maintaining fertility, making it a better option than a hysterectomy. Laparoscopic and robotically assisted surgeries are instance of technological advancements that provide advantages like less blood loss, fewer complications, shorter hospital stays, and faster recovery. By improving patient comfort and compliance, these advances help the market grow. The desire is further enhanced with new advanced devices that eradicate fibroid tissue using high-energy waves and are incisionless. Increased research in reproductive health, improved acceptance of gynaecological medical devices, and increased healthcare expenditure highlight the growth of the overall market.

Report Coverage

This research report categorizes the market for the Germany myomectomy market based on various segments and regions and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Germany myomectomy market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Germany myomectomy market.

Driving Factors

The need for efficient myomectomy techniques is fuelled in large part by the growing incidence of uterine fibroids in Germany. Increased awareness and better screening techniques have led to more diagnoses and more women seeking fertility-preserving treatments. The management of uterine architecture with myomectomy has also emerged as a recommended intervention option. Medical imaging advancements are also significant because they increase the rate of detection and, in turn, generate demand for efficient treatment alternatives that support market expansion.

Restraining Factors

The significant commercial barrier is the high risk of fibroids returning following myomectomy, which can occur in as many as 50% of patients. This recurrence often deters patients from initially choosing surgery because it necessitates additional operations. Another barrier to market expansion is the expense of recurring surgery, which is especially problematic in low-resource settings because patients may lose faith in the long-term effects of surgery. These factors hamper the myomectomy market during the forecast period.

Market Segmentation

The Germany myomectomy market share is classified into type and product.

• The abdominal segment held the largest market share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The Germany myomectomy market is segmented by type into abdominal, hysteroscopic, and laparoscopic. Among these, the abdominal segment held the largest market share in 2024 and is expected to grow at a significant CAGR during the forecast period. It is necessary to propose myomectomy procedures due to the rise of uterine fibroids. The most common and widely utilised approach to treating fibroids is this one. Simply stated, this surgical procedure is the accepted standard of care for uterine fibroid removal. It preserves the uterus and permits patients to remain fertile, making it a dependable, long-term approach to treating uterine fibroids.

• The laparoscopic sealer segment held the highest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The Germany myomectomy market is segmented by product into laparoscopic power morcellators, harmonic scalpel, laparoscopic sealer, and others. Among these, the laparoscopic sealer segment held the highest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period. The myomectomy operations are less invasive than traditional surgery, which is linked to smaller incisions, less bleeding, shorter hospital stays, and quicker recovery times. More people are choosing them. Because laparoscopic sealers enable precise tissue sealing and cutting, their use also improves surgical precision and lowers the risk of complications.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the Germany myomectomy market and a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Karl Storz SE & Co. KG
• B. Braun Melsungen AG
• Richard Wolf GmbH
• Medtronic
• Stryker Corporation
• Boston Scientific
• CONMED Corporation
• Olympus Corporation
• Siemens Healthineers
• Smith & Nephew
• Others

Key Target Audience

• Investors
• Market players
• End-users
• Government Authorities
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at Germany, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the Germany myomectomy market based on the below-mentioned segments:

Germany Myomectomy Market, By Type

• Abdominal
• Hysteroscopic
• Laparoscopic 

Germany Myomectomy Market, By Product

• Laparoscopic Power Morcellators
• Harmonic Scalpel
• Laparoscopic Sealer
• Others